Seelos Therapeutics Inc (SEEL)

[mean gene]

I am also a long term holder for over three years. I currently own more shares than when I originally started and my average price is @ $3.54. I do not agree that a substantial long term holders have sold or reduced their holdings. In the last three months the share price has dropped @ 36% and there has been @ 9 million shares traded, now keep in mind that for every seller there is a buyer. Lets assume that all these shares traded in the last 3 months were shareholders dumping their shares for the reasons you stated, that would amount to @ 23% of the 38 million outstanding shares. I would not call that most of long term holders selling or reducing their shares. The 73% are probably making a wise decision that Vitaros will sell and the company will be rewarded with milestone payments and royalties. This company imo is not counting on Femprox for its total success and I can understand why someone who invested in this company for the potential of Femprox would be disappointed; however, three years ago the push was for Vitaros to be approved and stay afloat financially. This has been accomplished and the pipeline products are still in the works. I do not believe for a minute that Femprox is dead, postponed because of favorable terms or risk, but not dead. Rayva is a pleasant surprise and imo I feel we will have other surprises because of the technology this company owns. I am not pumping this stock, I am as disappointed as many of you are with the current pps; however, I am not a believer that most are headed for exists.